Home
About Us
Who Are We ?
Vision & Mission
Promoters
Manufacturing Sites
BLL (WHO-GMP)
------
Brooks Steriscience
Our Products
General Products
Liquid Injection Ampoules
Liquid Injection Vials
Dry Powder Injection Vials
Lyophilized Injections
Eye/Ear Drops
Nasal Drops
β-Lactam Range
Tablets
Dry Powder Syrup
Injection
Cephalosporin Range
Tablets
Dry Powder Syrup
Injection
Sales & Marketing
India
CCD
Institutional Business
CDMO Services
International
Our Global Presence
Investors
Investors Forum
Committee Details
Contact Us
Product Enquiry
Investor Enquiry
Career Enquiry
Disclosure under Regulation 30
Details of Business
Disclaimer
Financial Results
Annual Report
Annual Return
MOA AOA
Preferential Allotment
List of Directors
Shareholding Pattern
Newspaper Advertisements
Policies
Notices
Voting Results
Disclosure Under Regulation-30
Secreterial Compliance Report
Annual Reports of Subsidiary Companies
Related Party Transaction
Investors Contact
Investor Forms
Right Issue
Prospectus
Credit Rating
Select Financial Year
FY 2024 - 2025
FY 2023 - 2024
FY 2022 - 2023
FY 2021 - 2022
FY 2020 - 2021
FY 2019 - 2020
FY 2018 - 2019
FY 2017 - 2018
FY 2016 - 2017
FY 2015 - 2016
FY
2024 - 2025
NSE Approval pre in Principal
Pre in Principal Approval BSE
Listing Approval BSE
Listing Approval NSE
Trading Window Closure
Revised Outcome alongwith Financial Results 31st December 2024
Outcome alongwith Financial Results 31st December 2024
Outcome for Allotment of Equity Shares
EOGM -Transcript
Agreement Disclosure
Fund Raising Committee Outcome
Outcome of Board Meeting for Statutory Auditor Appointment
Independent Director Cessation
Independent Director Appointment
Audited Financial Results for the Period Ended 31st March 2024
Certificate under Regulation 74(5) of SEBI (DP)
Regulation 30 - Fund Raising
Postal Ballot Notice-2022
Litigations
Deviation
Agreement Disclosure
Proceeding of 21st AGM
Outcome of Board Meeting for Allotment of Rights Shares
Resignation of Mrs. Kaushlaya Singh
Appointment of Mr. Bhushan Singh Rana as Additonal director
Intimation regarding Extension of Rights Issue Closing Date
Press Release
Disclosure of Regulation 30
Resignation of Mr. Manpreet Singh Naroo
BSE_Deviation statement
Notice of Postal Ballot
Rajesh Mahajan Resignation
Kaushalya Singh Appointment
Jitendra Singh Appointment
Company Secretary Appointment
Atul Ranchal Resignation
Approval for Meropenem Injection 500mg per vial and 1gm per vial from USFDA
Resignation of Company Secretary
Market Authorization UK
Resignation of Mrs. Kaushalya Singh, Whole Time Director of the Company
Transcript 21st AGM of Brooks Laboratories Limited
listing obligations and disclosure requirements
Listing Obligations and Disclosure Requirements
Disclosure of Regulation 30
Disclosure of Regulation 30 - 07/12/2019
Disclosure of Regulation 30 - 26/08/2019
Listing and Obligations disclosure
Credit Rating
Disclosure of Reg.30
Credit rating
Intimation under regulation 30